|
Market Closed -
Nasdaq
16:00:00 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 26.89 USD | -8.54% |
|
-2.36% | -25.90% |
| 08-12 | Mineralys Therapeutics, Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-11 | Mineralys Therapeutics Q2 Loss Widens | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MLYS | Delayed | |
CBOE
| MLYS | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 31.54 | 31.54 | 31.5 |
| Spread/Res. | -14.74% | -14.74% | -14.63% |
| Spread/Supp. | +6.41% | +19.51% | +13.84% |
| Support | 25.27 | 22.5 | 23.62 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MLYS Stock
- Charts Mineralys Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
